U.S. Enteral Feeding Formulas Market Size & Outlook
U.S. enteral feeding formulas market, 2018-2030 (US$M)
Related Markets
U.S. enteral feeding formulas market highlights
- The U.S. enteral feeding formulas market generated a revenue of USD 1,918.6 million in 2023 and is expected to reach USD 2,870.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
- In terms of segment, oral was the largest revenue generating product in 2023.
- Oral is the most lucrative product segment registering the fastest growth during the forecast period.
Enteral feeding formulas market data book summary
| Market revenue in 2023 | USD 1,918.6 million |
| Market revenue in 2030 | USD 2,870.3 million |
| Growth rate | 5.9% (CAGR from 2023 to 2030) |
| Largest segment | Oral |
| Fastest growing segment | Oral |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Enteral |
| Key market players worldwide | Abbott Laboratories, Danone SA, Fresenius SE & Co KGaA, Nestle SA, Meiji Holdings Co Ltd, Reckitt Benckiser Group PLC, Victus, Primus Pharmaceuticals |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.6% of the global enteral feeding formulas market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. enteral feeding formulas market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 322.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Enteral Feeding Formulas Market Scope
Enteral Feeding Formulas Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. enteral feeding formulas market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enteral feeding formulas market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 91.13% in 2023. Horizon Databook has segmented the U.S. enteral feeding formulas market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest market share of North America enteral feeding formulas market. In the U.S., a large number of individuals are suffering from head & neck cancer, which is expected to boost the adoption of these formulas.
For instance, according to CDC, in 2019, 47,813 new cases of oral cavities and pharynx cancer were reported in the country. Moreover, increasing incidence of various chronic diseases such as neurological diseases is anticipated to increase the applications of enteral feeding formulas during the forecast period.
For instance, according to The Alzheimer's Association's 2022 Report in the U.S., approximately 6.5 million individuals lived with Alzheimer’s disease in 2022. According to Parkinson’s Foundation, around 60,000 people are diagnosed with Parkinson’s disease each year in the U.S., and over 930,000 people had been living with Parkinson’s disease as of 2020.
Reasons to subscribe to U.S. enteral feeding formulas market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. enteral feeding formulas market databook
-
Our clientele includes a mix of enteral feeding formulas market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. enteral feeding formulas market , including forecasts for subscribers. This country databook contains high-level insights into U.S. enteral feeding formulas market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. enteral feeding formulas market size, by stage, 2018-2030 (US$M)
U.S. Enteral Feeding Formulas Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
